Abiopharma

🔍 Ling Geoffrey M.D. (Director)

Company: Celularity Inc (CELU)

Report Date: 2026-01-12

Detailed Transactions and Holdings:

• Acquired 19,231 shares of Class A Common Stock (Direct)
  Date: 2026-01-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 256,026.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
• F2: Includes 19,231 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.